Surgery Partners (SGRY) Capital Expenditures (2014 - 2026)

Surgery Partners has disclosed Capital Expenditures across 13 years of filings, most recently posting $21.8 million for Q2 2026.

• In Q2 2026, Capital Expenditures fell 6.84% year-over-year to $21.8 million; the TTM figure through Jun 2026 stood at $70.4 million (down 20.54% YoY), while the FY2025 annual figure was $78.7 million, down 12.94% from the prior year.
• Capital Expenditures came in at $21.8 million for Q2 2026 at Surgery Partners, up from $16.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $26.9 million in Q2 2024 to a low of $12.8 million in Q4 2025.
• Average Capital Expenditures over 5 years is $20.9 million, with a median of $21.4 million recorded in 2024.
• Year-over-year, Capital Expenditures jumped 65.93% in 2022 and sank 42.6% in 2025.
• Over 5 years, Capital Expenditures stood at $22.7 million in 2022, then slipped by 12.78% to $19.8 million in 2023, then gained by 12.63% to $22.3 million in 2024, then slumped by 42.6% to $12.8 million in 2025, then surged by 70.31% to $21.8 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $21.8 million in Q2 2026, $16.0 million in Q1 2026, and $12.8 million in Q4 2025.